Corgi U.S. Biotech 2x Daily ETF

XBIX seeks to deliver 200% of the daily performance of SPDR S&P Biotech ETF (Ticker: XBI), a passively managed ETF with a targeted exposure to US biotechnology stocks. Rather than holding XBI directly, the fund primarily uses derivatives such as swap agreements and options to create leveraged exposure. The portfolio is rebalanced at the end of each trading day to maintain its targeted leverage level, meaning returns over periods longer than a single day can differ significantly from two times the cumulative return of XBI due to compounding effects. The fund may also obtain leveraged exposure through exchange-traded equity futures contracts and exchange-traded options contracts, including standardized call and put options. Collateral supporting these derivative positions may be invested in money market instruments, repurchase agreements, or short-term US government securities.